LCPUFA supplemented formula showed no clear difference in visual acuity/Teller cards at 12 months (cycles/degree) ‐ DHA and AA… compared with control formula (low certainty).
LCPUFA supplemented formula showed no clear difference in sweep VEP acuity at 12 months (LogMAR) ‐ DHA and AA vs normal term… compared with control formula (low certainty).
LCPUFA supplemented formula showed no clear difference in MDI scores (Bayley) at 18 months ‐ DHA and AA vs normal term formula compared with control formula (low certainty).
LCPUFA supplemented formula showed no clear difference in PDI scores (Bayley) at 18 months ‐ DHA and AA vs normal term formula compared with control formula (low certainty).
LCPUFA supplemented formula showed no clear difference in weight at 12 months (z scores) ‐ DHA and AA vs normal term formula compared with control formula (low certainty).
LCPUFA supplemented formula showed no clear difference in length at 12 months (z scores) ‐ DHA and AA vs normal term formula compared with control formula (low certainty).
LCPUFA supplemented formula showed no clear difference in head circumference at 12 months (z scores) ‐ DHA and AA vs normal… compared with control formula (low certainty).
It is very uncertain whether higher changes all allergic disease ‐ infant incidence compared with lower PUFA intake (very low certainty).
It is very uncertain whether higher changes all allergic disease ‐ childhood prevalence compared with lower PUFA intake (very low certainty).
It is very uncertain whether higher changes asthma ‐ childhood prevalence compared with lower PUFA intake (very low certainty).
It is very uncertain whether higher changes dermatitis/eczema ‐ childhood prevalence compared with lower PUFA intake (very low certainty).
It is very uncertain whether higher changes allergic rhinitis ‐ childhood prevalence compared with lower PUFA intake (very low certainty).
It is very uncertain whether higher changes food allergy ‐ childhood prevalence compared with lower PUFA intake (very low certainty).
Higher showed no clear difference in asthma ‐ infant incidence compared with lower PUFA intake (low certainty).
It is very uncertain whether higher changes dermatitis/eczema ‐ infant incidence compared with lower PUFA intake (very low certainty).
It is very uncertain whether higher changes allergic rhinitis ‐ infant incidence compared with lower PUFA intake (very low certainty).
It is very uncertain whether higher changes food allergy ‐ infant incidence compared with lower PUFA intake (very low certainty).
It is very uncertain whether higher changes all allergic disease ‐ childhood incidence compared with lower PUFA intake (very low certainty).
It is very uncertain whether higher changes asthma ‐ childhood incidence compared with lower PUFA intake (very low certainty).
It is very uncertain whether higher changes dermatitis/eczema ‐ childhood incidence compared with lower PUFA intake (very low certainty).